Cargando…
Valvular heart disease as a possible predictor of trastuzumab-induced cardiotoxicity in patients with breast cancer
Although the use of trastuzumab has been reported to improve overall survival in patients with HER2-positive breast cancer, there is increasing concern about the adverse effects of trastuzumab-induced cardiotoxicity (TIC). The aim of the present study was to investigate the predictor of TIC and to c...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313940/ https://www.ncbi.nlm.nih.gov/pubmed/30655975 http://dx.doi.org/10.3892/mco.2018.1764 |